Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension

Published:2016-11 Issue: Volume:171 Page:35-46
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Yamamoto Tetsuya^ORCID,Ikegami Toru^ORCID,Ishikawa Yuji^ORCID,Kikuchi Satoru^ORCID

Publisher

Elsevier BV

Subject

Ophthalmology

Reference35 articles.

1. Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern® Guidelines;Prum;Ophthalmology,2016

2. The number of people with glaucoma worldwide in 2010 and 2020;Quigley;Br J Ophthalmol,2006

3. The Japan Glaucoma Society guidelines for glaucoma (3rd edition);Nippon Ganka Gakkai Zasshi,2012

4. Pharmacotherapy of glaucoma;Schmidl;J Ocul Pharmacol Ther,2015

5. Role of fixed combinations in the management of open-angle glaucoma;Hommer;Expert Rev Pharmacoecon Outcomes Res,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequent self-monitoring of intraocular pressure can determine effectiveness of medications in eyes with normal tension glaucoma: A case report;Medicine;2022-12-30

2. Topical Medication Therapy for Glaucoma and Ocular Hypertension;Frontiers in Pharmacology;2021-12-01

3. Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial;International Journal of Ophthalmology;2021-10-18

4. Comparison of the 24-h efficacy and safety of fixed combination carteolol/latanoprost and timolol/latanoprost in patients with primary open-angle glaucoma and ocular hypertension: a prospective crossover study;Japanese Journal of Ophthalmology;2021-07-19

5. Prostanoid receptor agonists for glaucoma treatment;Japanese Journal of Ophthalmology;2021-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3